State of Wyoming’s Inovio Pharmaceuticals INO Stock Holding History

State of Wyoming’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-29	Closed	-$3K	–	1269
2021 Q2	$3K	Buy	29 +19	+190%	+$1.82K	﹤0.01%	1095
2021 Q1	$1K	Buy	+10	New	+$1.31K	﹤0.01%	489

Other funds holding INO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State of Wyoming's INO Position: Q3 2021 in Review

State of Wyoming sold out of Inovio Pharmaceuticals (INO) in Q3 2021, closing a stake of 29 shares — an estimated $3K sold.

State of Wyoming first reported a position in INO in Q1 2021 and held it in 2 quarters. The position peaked at $3K in Q2 2021. 213 funds tracked by Wall St. Rank hold INO as of Q3 2021.

State of Wyoming reported no remaining Inovio Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
State of Wyoming sold 29 Inovio Pharmaceuticals shares in Q3 2021, an estimated $3K.
State of Wyoming first reported a position in Inovio Pharmaceuticals in Q1 2021 and held it in 2 quarters.
State of Wyoming's Inovio Pharmaceuticals position peaked at $3K in Q2 2021.
213 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2021.

Based on State of Wyoming's 13F filing for Q3 2021, filed 11 Feb 2022.